- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- March 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- October 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- October 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- March 2024
- 136 Pages
Global
From €3890EUR$4,250USD£3,306GBP
- Report
- January 2022
- 132 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- January 2025
- 94 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- October 2024
- 105 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- April 2024
- 217 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- February 2024
- 79 Pages
North America
From €3158EUR$3,450USD£2,684GBP
- Report
- February 2024
- 83 Pages
Africa, Middle East
From €3158EUR$3,450USD£2,684GBP
- Report
- September 2023
- 173 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- June 2023
- 115 Pages
United States
From €3158EUR$3,450USD£2,684GBP
- Report
- November 2023
- 178 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- August 2023
- 85 Pages
United States
From €4440EUR$4,850USD£3,773GBP
- Report
- April 2023
- 108 Pages
Europe
From €3158EUR$3,450USD£2,684GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more